1-(2-hydroxy-3-prop-2-enylphenyl)-2-(triphenyl-λ5-phosphanylidene)propan-1-one
C30H27O2P — CID 15666668
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2-hydroxy-3-prop-2-enylphenyl)-2-(triphenyl-λ5-phosphanylidene)propan-1-one
1-(2-hydroxy-3-prop-2-enylphenyl)-2-(triphenyl-λ5-phosphanylidene)propan-1-one (PubChem CID 15666668) has the molecular formula C30H27O2P and a molecular weight of 450.52 g/mol. Its IUPAC name is 1-(2-hydroxy-3-prop-2-enylphenyl)-2-(triphenyl-λ5-phosphanylidene)propan-1-one.
Molecular Properties
| Compound Name | 1-(2-hydroxy-3-prop-2-enylphenyl)-2-(triphenyl-λ5-phosphanylidene)propan-1-one |
|---|---|
| PubChem CID | 15666668 |
| Molecular Formula | C30H27O2P |
| Molecular Weight | 450.52 g/mol |
| Exact Mass | 450.17 |
| IUPAC Name | 1-(2-hydroxy-3-prop-2-enylphenyl)-2-(triphenyl-λ5-phosphanylidene)propan-1-one |
| SMILES | C=CCc1cccc(C(=O)C(C)=P(c2ccccc2)(c2ccccc2)c2ccccc2)c1O |
| InChI | InChI=1S/C30H27O2P/c1-3-14-24-15-13-22-28(30(24)32)29(31)23(2)33(25-16-7-4-8-17-25,26-18-9-5-10-19-26)27-20-11-6-12-21-27/h3-13,15-22,32H,1,14H2,2H3 |
| InChIKey | WTGOVKZVZBWZND-UHFFFAOYSA-N |
| XLogP | 5.49 |
| TPSA | 37.30 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 450.52 |
| LogP ≤ 5 | 5.49 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_one_A(321)', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15666668 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.